Answers are grounded in this paper and cite their sources.
This study corroborates previous work demonstrating correlations of MBP, NSE, and S100beta with clinical and radiographic features in acute stroke. Despite significantly better outcomes in the tissue plasminogen activator-treated group, we found no difference in the early release of the 4 biomarkers between treatment groups. Further study will define the role of biomarkers in acute stroke management and prognostication.
No takes yet. Share an insight, caveat, or question.
Jauch et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: